Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
about
Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats.Fungal Pathogens in CF Airways: Leave or Treat?
P2860
Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Colistimethate sodium dry powd ...... patients with cystic fibrosis.
@en
type
label
Colistimethate sodium dry powd ...... patients with cystic fibrosis.
@en
prefLabel
Colistimethate sodium dry powd ...... patients with cystic fibrosis.
@en
P2860
P1433
P1476
Colistimethate sodium dry powd ...... patients with cystic fibrosis.
@en
P2093
Daniel Conole
P2860
P2888
P304
P356
10.1007/S40265-014-0181-0
P577
2014-03-01T00:00:00Z
P5875
P6179
1003198000